Hudson Value Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.35M Buy
16,653
+3,317
+25% +$1.59M 2.1% 14
2026
Q1
$6.55M Buy
13,336
+2,713
+26% +$1.47M 1.96% 20
2025
Q4
$6.19M Buy
10,623
+9
+0.1% +$5.09K 1.84% 18
2025
Q3
$5.15M Buy
10,614
+1,356
+15% +$631K 1.59% 23
2025
Q2
$3.75M Buy
+9,258
New +$3.87M 1.3% 31

Other funds holding TMO

Hudson Value Partners's TMO Position: Q2 2026 in Review

Hudson Value Partners increased its Thermo Fisher Scientific (TMO) stake by 25% in Q2 2026, buying an estimated $1.59M and bringing the position to 16,653 shares worth $8.35M. The position accounts for 2.1% of the portfolio, ranked #14.

Hudson Value Partners first reported a position in TMO in Q2 2025 and has held it in 5 quarters since. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Hudson Value Partners held 16,653 shares of Thermo Fisher Scientific worth $8.35M as of Q2 2026.
  • Hudson Value Partners bought 3,317 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.59M.
  • Thermo Fisher Scientific made up 2.1% of Hudson Value Partners's portfolio in Q2 2026, its #14 holding.
  • Hudson Value Partners first reported a position in Thermo Fisher Scientific in Q2 2025 and has held it in 5 quarters since.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Hudson Value Partners's 13F filing for Q2 2026, filed 10 Jul 2026.